Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs
NCT07919600, Not applicable, Recruiting, Hatice Zehra FERHATLAR
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs | ClinicalTrials.gov |
| NCT number | NCT07919600 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 100 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Hatice Zehra FERHATLAR | ClinicalTrials.gov |
| Conditions | Calcaneal Spur | ClinicalTrials.gov |
| Interventions | Active Pulsed Electromagnetic Field Therapy (PEMF), Sham Pulsed Electromagnetic Field Therapy (Sham PEMF) | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-05 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Morning First-Step Pain Intensity Assessed by Visual Analog Scale (VAS) | Baseline (Week 0), Week 4, Week 8, and Week 12 | Morning first-step heel pain intensity will be assessed using a Visual Analog Scale (VAS), with higher scores indicating greater pain intensity. The change from baseline will be compared between the active PEMF and sham PEMF groups at weeks 4, 8, and 12. | ClinicalTrials.gov |
| Secondary | Change in Foot Function Index (FFI) Score | Baseline (Week 0), Week 4, Week 8, and Week 12 | Foot-related pain, disability, and functional limitations will be assessed using the Foot Function Index (FFI). Higher scores indicate greater foot-related pain and disability. Changes from baseline will be compared between the active PEMF and sham PEMF groups. | ClinicalTrials.gov |
| Secondary | Change in Plantar Fascia Thickness Measured by Ultrasonography | Baseline (Week 0), Week 4, Week 8, and Week 12 | Plantar fascia thickness will be measured using ultrasonography and recorded in millimeters (mm). Changes in plantar fascia thickness from baseline will be evaluated and compared between the active PEMF and sham PEMF groups at each follow-up visit. | ClinicalTrials.gov |
| Secondary | Change in Pressure Pain Threshold (PPT) at the Medial Calcaneal Region | Baseline (Week 0), Week 4, Week 8, and Week 12 | Pressure pain threshold (PPT) will be measured using a pressure algometer at the medial calcaneal region. Higher PPT values indicate lower mechanical pain sensitivity. Changes from baseline will be compared between the active PEMF and sham PEMF groups at weeks 4, 8, and 12. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 3
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)